Clincosm LogoSign in Get a demo

idiopathic hypersomnia

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Hypersomnia Trial in Paris (EEG (64 electrodes), Cognitive task (SART), Pupillometry and eye tracking)

Not yet recruiting
  • Idiopathic Hypersomnia
  • EEG (64 electrodes)
  • +3 more
  • Paris, France
    Pitié Salpêtrière
Nov 29, 2023

Idiopathic Hypersomnia, Narcolepsy Trial (JZP258 (XYWAV))

Not yet recruiting
  • Idiopathic Hypersomnia
  • Narcolepsy
  • JZP258 (XYWAV)
  • (no location specified)
May 16, 2023

Idiopathic Hypersomnia Trial in United States (drug, diagnostic test, device)

Not yet recruiting
  • Idiopathic Hypersomnia
  • Low Sodium Oxybate
  • +3 more
  • Phoenix, Arizona
  • +3 more
Apr 19, 2023

Psychiatric Co-morbidities and Socio-demographic Characteristics

Recruiting
  • Idiopathic Hypersomnia
  • +2 more
  • respond to questionnaires by telephone
  • Toulouse, France
    Chu Toulouse
Mar 9, 2023

Idiopathic Hypersomnia Trial in United States (Serdexmethylphenidate, Placebo)

Recruiting
  • Idiopathic Hypersomnia
  • Birmingham, Alabama
  • +34 more
Dec 29, 2022

Idiopathic Hypersomnia, Excessive Daytime Sleepiness Trial in United States (pitolisant)

Enrolling by invitation
  • Idiopathic Hypersomnia
  • Excessive Daytime Sleepiness
  • Peoria, Arizona
  • +57 more
Nov 10, 2022

Narcolepsy, Idiopathic Hypersomnia, Cataplexy Trial (Quantitative mass spectrometry assay)

Not yet recruiting
  • Narcolepsy
  • +2 more
  • Quantitative mass spectrometry assay
  • (no location specified)
Nov 7, 2022

Sleep Disorder, Sleep Disorder Parasomnia, Narcolepsy Trial in Mainz (no interventions, only observation)

Recruiting
  • Sleep Disorder
  • +8 more
  • Implantation of vagus nerve stimulation according to clinical indication
  • Mainz, Rheinland-Pfalz, Germany
    Mainz Comprehensive Epilepsy and Sleep Medicine Center
Sep 11, 2022

Idiopathic Hypersomnia, Narcolepsy Without Cataplexy Trial in Atlanta (Modafinil, Amphetamine-Dextroamphetamine)

Recruiting
  • Idiopathic Hypersomnia
  • Narcolepsy Without Cataplexy
  • Atlanta, Georgia
    Emory Sleep Center
Jul 13, 2022

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Narcolepsy Without Cataplexy, Idiopathic Hypersomnia Trial in Atlanta (Clarithromycin, Placebo)

    Recruiting
    • Narcolepsy Without Cataplexy
    • Idiopathic Hypersomnia
    • Atlanta, Georgia
      Emory Sleep Center
    Jun 15, 2022

    Idiopathic Hypersomnia Trial in United States (Pitolisant Oral Tablet, Placebo oral tablet)

    Recruiting
    • Idiopathic Hypersomnia
    • Pitolisant Oral Tablet
    • Placebo oral tablet
    • Scottsdale, Arizona
    • +50 more
    Jun 14, 2022

    Cardiovascular and Cognitive Implications of Central Disorders

    Enrolling by invitation
    • Narcolepsy
    • Idiopathic Hypersomnia
    • 24-hour Ambulatory Blood Pressure Monitoring
    • Oculo-Cognitive Addition Test (OCAT)
    • Scottsdale, Arizona
      Mayo Clinic Arizona
    May 27, 2022

    Narcolepsy, Idiopathic Hypersomnia, Hypersomnolence Disorder Trial in Bern

    Recruiting
    • Narcolepsy
    • +2 more
      • Bern, Switzerland
        Claudio L Bassetti
      May 17, 2022

      Idiopathic Hypersomnia Trial in Worldwide (JZP-258, Placebo Oral Solution)

      Completed
      Has Results
      • Idiopathic Hypersomnia
      • Birmingham, Alabama
      • +62 more
      Nov 18, 2021

      Anesthetic Management of Patients With Chronic Sleep Disorders

      Completed
      • Narcolepsy
      • +2 more
      • Questionnaire
      • Montpellier, France
        Uhmontpellier
      Sep 6, 2021

      Idiopathic Hypersomnia Trial in Japan, United States (TAK-925, TAK-925 Placebo)

      Completed
      • Idiopathic Hypersomnia
      • Alabaster, Alabama
      • +21 more
      Mar 4, 2021

      Narcolepsy 1, Idiopathic Hypersomnia Trial in Zürich (Sleep restriction, Sleep deprivation)

      Completed
      • Narcolepsy 1
      • Idiopathic Hypersomnia
      • Sleep restriction
      • Sleep deprivation
      • Zürich, Switzerland
        University Hospital Zurich
      Feb 19, 2021

      Idiopathic Hypersomnia Trial in Montpellier (Sodium Oxybate Oral Solution 500 MG/ML, Placebos)

      Recruiting
      • Idiopathic Hypersomnia
      • Sodium Oxybate Oral Solution 500 MG/ML
      • Placebos
      • Montpellier, France
        University Hospital of Montpellier
      Feb 11, 2021

      Idiopathic Hypersomnia Trial in United States (Pentetrazol (PTZ), Placebo oral capsule)

      Unknown status
      • Idiopathic Hypersomnia
      • Pentetrazol (PTZ)
      • Placebo oral capsule
      • Birmingham, Alabama
      • +31 more
      Apr 28, 2020

      Narcolepsy, Idiopathic Hypersomnia Trial in Chicago (Cognitive-Behavior Therapy for Hypersomnia (CBT-H))

      Completed
      • Narcolepsy
      • Idiopathic Hypersomnia
      • Cognitive-Behavior Therapy for Hypersomnia (CBT-H)
      • Chicago, Illinois
        Center for Circadian and Sleep Medicine, Northwestern University
      Nov 19, 2019

      Idiopathic Hypersomnia, Narcolepsy Without Cataplexy Trial in United States (BTD-001, Placebo)

      Completed
      • Idiopathic Hypersomnia
      • Narcolepsy Without Cataplexy
      • Birmingham, Alabama
      • +22 more
      Jan 14, 2019

      Hypersomnia, Primary Hypersomnia, Idiopathic Hypersomnia Trial in Atlanta (Flumazenil)

      Completed
      Has Results
      • Hypersomnia
      • +3 more
      • Atlanta, Georgia
        Emory Sleep Center
      Nov 6, 2017

      Hypersomnia, Idiopathic Hypersomnia, Narcolepsy Trial in Atlanta (Clarithromycin followed by , Placebo then Clarithromycin)

      Completed
      Has Results
      • Hypersomnia
      • +2 more
      • Clarithromycin followed by placebo
      • Placebo then Clarithromycin
      • Atlanta, Georgia
        Emory Sleep Center
      Oct 5, 2017